Treatment of pluripotent cells
US9845460B2 · kind B2 · utility
0Cited by
61References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2013 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | Nov 20, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is provides a method for treating human pluripotent cells. In particular, the methods of the invention are directed to the treatment of human pluripotent cells, whereby the human pluripotent cells can be efficiently expanded in culture and differentiated by treating the pluripotent cells with an inhibitor of glycogen synthase kinase 3β (GSK-3B) enzyme activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.